Pediatric Research
Subject Area and Category
- Pediatrics, Perinatology and Child Health
Lippincott Williams and Wilkins Ltd.
Publication type
00313998, 15300447
Information
How to publish in this journal
The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
Category | Year | Quartile |
---|---|---|
Pediatrics, Perinatology and Child Health | 1999 | Q1 |
Pediatrics, Perinatology and Child Health | 2000 | Q1 |
Pediatrics, Perinatology and Child Health | 2001 | Q1 |
Pediatrics, Perinatology and Child Health | 2002 | Q1 |
Pediatrics, Perinatology and Child Health | 2003 | Q1 |
Pediatrics, Perinatology and Child Health | 2004 | Q1 |
Pediatrics, Perinatology and Child Health | 2005 | Q1 |
Pediatrics, Perinatology and Child Health | 2006 | Q2 |
Pediatrics, Perinatology and Child Health | 2007 | Q1 |
Pediatrics, Perinatology and Child Health | 2008 | Q1 |
Pediatrics, Perinatology and Child Health | 2009 | Q1 |
Pediatrics, Perinatology and Child Health | 2010 | Q1 |
Pediatrics, Perinatology and Child Health | 2011 | Q1 |
Pediatrics, Perinatology and Child Health | 2012 | Q1 |
Pediatrics, Perinatology and Child Health | 2013 | Q1 |
Pediatrics, Perinatology and Child Health | 2014 | Q1 |
Pediatrics, Perinatology and Child Health | 2015 | Q1 |
Pediatrics, Perinatology and Child Health | 2016 | Q1 |
Pediatrics, Perinatology and Child Health | 2017 | Q1 |
Pediatrics, Perinatology and Child Health | 2018 | Q1 |
Pediatrics, Perinatology and Child Health | 2019 | Q1 |
Pediatrics, Perinatology and Child Health | 2020 | Q1 |
Pediatrics, Perinatology and Child Health | 2021 | Q1 |
Pediatrics, Perinatology and Child Health | 2022 | Q1 |
Pediatrics, Perinatology and Child Health | 2023 | Q1 |
The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
Year | SJR |
---|---|
1999 | 0.795 |
2000 | 0.777 |
2001 | 0.945 |
2002 | 1.169 |
2003 | 1.135 |
2004 | 1.153 |
2005 | 0.881 |
2006 | 0.685 |
2007 | 0.719 |
2008 | 0.918 |
2009 | 1.172 |
2010 | 1.294 |
2011 | 1.181 |
2012 | 1.385 |
2013 | 1.368 |
2014 | 1.417 |
2015 | 1.360 |
2016 | 1.439 |
2017 | 1.304 |
2018 | 1.339 |
2019 | 0.945 |
2020 | 1.056 |
2021 | 0.991 |
2022 | 1.040 |
2023 | 1.184 |
Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.
Year | Documents |
---|---|
1999 | 257 |
2000 | 286 |
2001 | 266 |
2002 | 281 |
2003 | 303 |
2004 | 578 |
2005 | 773 |
2006 | 316 |
2007 | 291 |
2008 | 249 |
2009 | 275 |
2010 | 214 |
2011 | 227 |
2012 | 203 |
2013 | 221 |
2014 | 196 |
2015 | 223 |
2016 | 259 |
2017 | 286 |
2018 | 328 |
2019 | 315 |
2020 | 406 |
2021 | 508 |
2022 | 571 |
2023 | 668 |
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
Cites per document | Year | Value |
---|---|---|
Cites / Doc. (4 years) | 1999 | 1.704 |
Cites / Doc. (4 years) | 2000 | 1.938 |
Cites / Doc. (4 years) | 2001 | 2.292 |
Cites / Doc. (4 years) | 2002 | 2.324 |
Cites / Doc. (4 years) | 2003 | 2.855 |
Cites / Doc. (4 years) | 2004 | 2.744 |
Cites / Doc. (4 years) | 2005 | 2.426 |
Cites / Doc. (4 years) | 2006 | 1.906 |
Cites / Doc. (4 years) | 2007 | 1.868 |
Cites / Doc. (4 years) | 2008 | 2.085 |
Cites / Doc. (4 years) | 2009 | 2.214 |
Cites / Doc. (4 years) | 2010 | 3.190 |
Cites / Doc. (4 years) | 2011 | 3.307 |
Cites / Doc. (4 years) | 2012 | 3.583 |
Cites / Doc. (4 years) | 2013 | 3.390 |
Cites / Doc. (4 years) | 2014 | 3.069 |
Cites / Doc. (4 years) | 2015 | 3.300 |
Cites / Doc. (4 years) | 2016 | 3.161 |
Cites / Doc. (4 years) | 2017 | 3.465 |
Cites / Doc. (4 years) | 2018 | 3.200 |
Cites / Doc. (4 years) | 2019 | 2.993 |
Cites / Doc. (4 years) | 2020 | 2.982 |
Cites / Doc. (4 years) | 2021 | 3.382 |
Cites / Doc. (4 years) | 2022 | 3.245 |
Cites / Doc. (4 years) | 2023 | 2.999 |
Cites / Doc. (3 years) | 1999 | 1.704 |
Cites / Doc. (3 years) | 2000 | 1.769 |
Cites / Doc. (3 years) | 2001 | 2.316 |
Cites / Doc. (3 years) | 2002 | 2.707 |
Cites / Doc. (3 years) | 2003 | 2.850 |
Cites / Doc. (3 years) | 2004 | 2.628 |
Cites / Doc. (3 years) | 2005 | 2.159 |
Cites / Doc. (3 years) | 2006 | 1.677 |
Cites / Doc. (3 years) | 2007 | 1.722 |
Cites / Doc. (3 years) | 2008 | 2.220 |
Cites / Doc. (3 years) | 2009 | 2.847 |
Cites / Doc. (3 years) | 2010 | 3.256 |
Cites / Doc. (3 years) | 2011 | 3.119 |
Cites / Doc. (3 years) | 2012 | 3.624 |
Cites / Doc. (3 years) | 2013 | 3.157 |
Cites / Doc. (3 years) | 2014 | 3.009 |
Cites / Doc. (3 years) | 2015 | 3.097 |
Cites / Doc. (3 years) | 2016 | 3.208 |
Cites / Doc. (3 years) | 2017 | 3.308 |
Cites / Doc. (3 years) | 2018 | 3.171 |
Cites / Doc. (3 years) | 2019 | 2.716 |
Cites / Doc. (3 years) | 2020 | 2.750 |
Cites / Doc. (3 years) | 2021 | 3.288 |
Cites / Doc. (3 years) | 2022 | 3.090 |
Cites / Doc. (3 years) | 2023 | 3.077 |
Cites / Doc. (2 years) | 1999 | 1.358 |
Cites / Doc. (2 years) | 2000 | 1.676 |
Cites / Doc. (2 years) | 2001 | 2.707 |
Cites / Doc. (2 years) | 2002 | 2.611 |
Cites / Doc. (2 years) | 2003 | 2.642 |
Cites / Doc. (2 years) | 2004 | 2.356 |
Cites / Doc. (2 years) | 2005 | 1.804 |
Cites / Doc. (2 years) | 2006 | 1.389 |
Cites / Doc. (2 years) | 2007 | 1.778 |
Cites / Doc. (2 years) | 2008 | 2.916 |
Cites / Doc. (2 years) | 2009 | 2.822 |
Cites / Doc. (2 years) | 2010 | 3.090 |
Cites / Doc. (2 years) | 2011 | 3.143 |
Cites / Doc. (2 years) | 2012 | 3.209 |
Cites / Doc. (2 years) | 2013 | 3.167 |
Cites / Doc. (2 years) | 2014 | 2.557 |
Cites / Doc. (2 years) | 2015 | 3.012 |
Cites / Doc. (2 years) | 2016 | 2.959 |
Cites / Doc. (2 years) | 2017 | 3.278 |
Cites / Doc. (2 years) | 2018 | 2.857 |
Cites / Doc. (2 years) | 2019 | 2.410 |
Cites / Doc. (2 years) | 2020 | 2.499 |
Cites / Doc. (2 years) | 2021 | 3.042 |
Cites / Doc. (2 years) | 2022 | 3.179 |
Cites / Doc. (2 years) | 2023 | 2.905 |
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.
Cites | Year | Value |
---|---|---|
Self Cites | 1999 | 173 |
Self Cites | 2000 | 102 |
Self Cites | 2001 | 169 |
Self Cites | 2002 | 101 |
Self Cites | 2003 | 128 |
Self Cites | 2004 | 150 |
Self Cites | 2005 | 156 |
Self Cites | 2006 | 128 |
Self Cites | 2007 | 122 |
Self Cites | 2008 | 102 |
Self Cites | 2009 | 132 |
Self Cites | 2010 | 77 |
Self Cites | 2011 | 89 |
Self Cites | 2012 | 70 |
Self Cites | 2013 | 74 |
Self Cites | 2014 | 63 |
Self Cites | 2015 | 56 |
Self Cites | 2016 | 60 |
Self Cites | 2017 | 97 |
Self Cites | 2018 | 90 |
Self Cites | 2019 | 98 |
Self Cites | 2020 | 97 |
Self Cites | 2021 | 143 |
Self Cites | 2022 | 212 |
Self Cites | 2023 | 239 |
Total Cites | 1999 | 2018 |
Total Cites | 2000 | 1957 |
Total Cites | 2001 | 2390 |
Total Cites | 2002 | 2190 |
Total Cites | 2003 | 2374 |
Total Cites | 2004 | 2234 |
Total Cites | 2005 | 2509 |
Total Cites | 2006 | 2774 |
Total Cites | 2007 | 2870 |
Total Cites | 2008 | 3064 |
Total Cites | 2009 | 2437 |
Total Cites | 2010 | 2654 |
Total Cites | 2011 | 2302 |
Total Cites | 2012 | 2595 |
Total Cites | 2013 | 2033 |
Total Cites | 2014 | 1959 |
Total Cites | 2015 | 1920 |
Total Cites | 2016 | 2053 |
Total Cites | 2017 | 2243 |
Total Cites | 2018 | 2435 |
Total Cites | 2019 | 2371 |
Total Cites | 2020 | 2555 |
Total Cites | 2021 | 3449 |
Total Cites | 2022 | 3797 |
Total Cites | 2023 | 4570 |
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.
Cites | Year | Value |
---|---|---|
External Cites per document | 1999 | 1.558 |
External Cites per document | 2000 | 1.677 |
External Cites per document | 2001 | 2.152 |
External Cites per document | 2002 | 2.582 |
External Cites per document | 2003 | 2.696 |
External Cites per document | 2004 | 2.452 |
External Cites per document | 2005 | 2.025 |
External Cites per document | 2006 | 1.600 |
External Cites per document | 2007 | 1.648 |
External Cites per document | 2008 | 2.146 |
External Cites per document | 2009 | 2.693 |
External Cites per document | 2010 | 3.162 |
External Cites per document | 2011 | 2.999 |
External Cites per document | 2012 | 3.527 |
External Cites per document | 2013 | 3.042 |
External Cites per document | 2014 | 2.912 |
External Cites per document | 2015 | 3.006 |
External Cites per document | 2016 | 3.114 |
External Cites per document | 2017 | 3.165 |
External Cites per document | 2018 | 3.053 |
External Cites per document | 2019 | 2.604 |
External Cites per document | 2020 | 2.646 |
External Cites per document | 2021 | 3.152 |
External Cites per document | 2022 | 2.917 |
External Cites per document | 2023 | 2.916 |
Cites per document | 1999 | 1.704 |
Cites per document | 2000 | 1.769 |
Cites per document | 2001 | 2.316 |
Cites per document | 2002 | 2.707 |
Cites per document | 2003 | 2.850 |
Cites per document | 2004 | 2.628 |
Cites per document | 2005 | 2.159 |
Cites per document | 2006 | 1.677 |
Cites per document | 2007 | 1.722 |
Cites per document | 2008 | 2.220 |
Cites per document | 2009 | 2.847 |
Cites per document | 2010 | 3.256 |
Cites per document | 2011 | 3.119 |
Cites per document | 2012 | 3.624 |
Cites per document | 2013 | 3.157 |
Cites per document | 2014 | 3.009 |
Cites per document | 2015 | 3.097 |
Cites per document | 2016 | 3.208 |
Cites per document | 2017 | 3.308 |
Cites per document | 2018 | 3.171 |
Cites per document | 2019 | 2.716 |
Cites per document | 2020 | 2.750 |
Cites per document | 2021 | 3.288 |
Cites per document | 2022 | 3.090 |
Cites per document | 2023 | 3.077 |
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.
Year | International Collaboration |
---|---|
1999 | 19.46 |
2000 | 18.88 |
2001 | 14.66 |
2002 | 3.20 |
2003 | 24.42 |
2004 | 12.98 |
2005 | 14.75 |
2006 | 24.68 |
2007 | 21.31 |
2008 | 26.10 |
2009 | 20.73 |
2010 | 27.57 |
2011 | 22.91 |
2012 | 24.14 |
2013 | 22.62 |
2014 | 23.47 |
2015 | 25.56 |
2016 | 30.12 |
2017 | 24.83 |
2018 | 22.87 |
2019 | 24.13 |
2020 | 26.35 |
2021 | 24.80 |
2022 | 24.17 |
2023 | 26.65 |
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.
Documents | Year | Value |
---|---|---|
Non-citable documents | 1999 | 3 |
Non-citable documents | 2000 | 11 |
Non-citable documents | 2001 | 29 |
Non-citable documents | 2002 | 46 |
Non-citable documents | 2003 | 57 |
Non-citable documents | 2004 | 72 |
Non-citable documents | 2005 | 72 |
Non-citable documents | 2006 | 68 |
Non-citable documents | 2007 | 46 |
Non-citable documents | 2008 | 46 |
Non-citable documents | 2009 | 48 |
Non-citable documents | 2010 | 51 |
Non-citable documents | 2011 | 41 |
Non-citable documents | 2012 | 33 |
Non-citable documents | 2013 | 29 |
Non-citable documents | 2014 | 22 |
Non-citable documents | 2015 | 21 |
Non-citable documents | 2016 | 18 |
Non-citable documents | 2017 | 25 |
Non-citable documents | 2018 | 54 |
Non-citable documents | 2019 | 106 |
Non-citable documents | 2020 | 180 |
Non-citable documents | 2021 | 256 |
Non-citable documents | 2022 | 323 |
Non-citable documents | 2023 | 360 |
Citable documents | 1999 | 1181 |
Citable documents | 2000 | 1095 |
Citable documents | 2001 | 1003 |
Citable documents | 2002 | 763 |
Citable documents | 2003 | 776 |
Citable documents | 2004 | 778 |
Citable documents | 2005 | 1090 |
Citable documents | 2006 | 1586 |
Citable documents | 2007 | 1621 |
Citable documents | 2008 | 1334 |
Citable documents | 2009 | 808 |
Citable documents | 2010 | 764 |
Citable documents | 2011 | 697 |
Citable documents | 2012 | 683 |
Citable documents | 2013 | 615 |
Citable documents | 2014 | 629 |
Citable documents | 2015 | 599 |
Citable documents | 2016 | 622 |
Citable documents | 2017 | 653 |
Citable documents | 2018 | 714 |
Citable documents | 2019 | 767 |
Citable documents | 2020 | 749 |
Citable documents | 2021 | 793 |
Citable documents | 2022 | 906 |
Citable documents | 2023 | 1125 |
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.
Documents | Year | Value |
---|---|---|
Uncited documents | 1999 | 539 |
Uncited documents | 2000 | 503 |
Uncited documents | 2001 | 397 |
Uncited documents | 2002 | 218 |
Uncited documents | 2003 | 209 |
Uncited documents | 2004 | 237 |
Uncited documents | 2005 | 463 |
Uncited documents | 2006 | 901 |
Uncited documents | 2007 | 903 |
Uncited documents | 2008 | 606 |
Uncited documents | 2009 | 201 |
Uncited documents | 2010 | 158 |
Uncited documents | 2011 | 141 |
Uncited documents | 2012 | 131 |
Uncited documents | 2013 | 132 |
Uncited documents | 2014 | 143 |
Uncited documents | 2015 | 122 |
Uncited documents | 2016 | 123 |
Uncited documents | 2017 | 137 |
Uncited documents | 2018 | 173 |
Uncited documents | 2019 | 235 |
Uncited documents | 2020 | 282 |
Uncited documents | 2021 | 313 |
Uncited documents | 2022 | 361 |
Uncited documents | 2023 | 436 |
Cited documents | 1999 | 645 |
Cited documents | 2000 | 603 |
Cited documents | 2001 | 635 |
Cited documents | 2002 | 591 |
Cited documents | 2003 | 624 |
Cited documents | 2004 | 613 |
Cited documents | 2005 | 699 |
Cited documents | 2006 | 753 |
Cited documents | 2007 | 764 |
Cited documents | 2008 | 774 |
Cited documents | 2009 | 655 |
Cited documents | 2010 | 657 |
Cited documents | 2011 | 597 |
Cited documents | 2012 | 585 |
Cited documents | 2013 | 512 |
Cited documents | 2014 | 508 |
Cited documents | 2015 | 498 |
Cited documents | 2016 | 517 |
Cited documents | 2017 | 541 |
Cited documents | 2018 | 595 |
Cited documents | 2019 | 638 |
Cited documents | 2020 | 647 |
Cited documents | 2021 | 736 |
Cited documents | 2022 | 868 |
Cited documents | 2023 | 1049 |
Evolution of the percentage of female authors.
Year | Female Percent |
---|---|
1999 | 31.41 |
2000 | 35.24 |
2001 | 33.52 |
2002 | 40.03 |
2003 | 37.87 |
2004 | 39.79 |
2005 | 43.74 |
2006 | 40.67 |
2007 | 41.72 |
2008 | 41.12 |
2009 | 43.34 |
2010 | 40.13 |
2011 | 43.75 |
2012 | 43.96 |
2013 | 45.26 |
2014 | 43.80 |
2015 | 47.37 |
2016 | 51.24 |
2017 | 47.42 |
2018 | 47.83 |
2019 | 48.24 |
2020 | 51.31 |
2021 | 51.88 |
2022 | 52.77 |
2023 | 53.43 |
Evolution of the number of documents cited by public policy documents according to Overton database.
Documents | Year | Value |
---|---|---|
Overton | 1999 | 28 |
Overton | 2000 | 47 |
Overton | 2001 | 39 |
Overton | 2002 | 34 |
Overton | 2003 | 6 |
Overton | 2004 | 15 |
Overton | 2005 | 16 |
Overton | 2006 | 38 |
Overton | 2007 | 26 |
Overton | 2008 | 1 |
Overton | 2009 | 0 |
Overton | 2010 | 0 |
Overton | 2011 | 0 |
Overton | 2012 | 29 |
Overton | 2013 | 37 |
Overton | 2014 | 26 |
Overton | 2015 | 36 |
Overton | 2016 | 55 |
Overton | 2017 | 38 |
Overton | 2018 | 33 |
Overton | 2019 | 21 |
Overton | 2020 | 26 |
Overton | 2021 | 35 |
Overton | 2022 | 13 |
Overton | 2023 | 9 |
Evoution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.
Documents | Year | Value |
---|---|---|
SDG | 2018 | 86 |
SDG | 2019 | 63 |
SDG | 2020 | 91 |
SDG | 2021 | 160 |
SDG | 2022 | 153 |
SDG | 2023 | 200 |
Leave a comment
Name * Required
Email (will not be published) * Required
* Required Cancel
The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.
Follow us on @ScimagoJR Scimago Lab , Copyright 2007-2024. Data Source: Scopus®
Cookie settings
Cookie Policy
Legal Notice
Privacy Policy
Pediatric Research - Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details
Published By: Lippincott Williams and Wilkins Ltd.
Abbreviation: Pediatr. Res.
Impact Score The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.
Important details.
Pediatric Research | |
Pediatr. Res. | |
Journal | |
Pediatrics, Perinatology and Child Health (Q1) | |
3.12 | |
1.040 | |
165 | |
3961 | |
Lippincott Williams and Wilkins Ltd. | |
United States | |
00313998, 15300447 | |
1967-2022 | |
Q1 | |
(Last 3 Year) | 3790 |
About Pediatric Research
Pediatric Research is a journal published by Lippincott Williams and Wilkins Ltd. . This journal covers the area[s] related to Pediatrics, Perinatology and Child Health, etc . The coverage history of this journal is as follows: 1967-2022. The rank of this journal is 3961 . This journal's impact score, h-index, and SJR are 3.12, 165, and 1.040, respectively. The ISSN of this journal is/are as follows: 00313998, 15300447 . The best quartile of Pediatric Research is Q1 . This journal has received a total of 3790 citations during the last three years (Preceding 2022).
Pediatric Research Impact Score 2022-2023
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Prediction of Pediatric Research Impact Score 2023
Impact Score 2022 of Pediatric Research is 3.12 . If a similar upward trend continues, IS may increase in 2023 as well.
Impact Score Graph
Check below the impact score trends of pediatric research. this is based on scopus data..
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 3.12 |
2021 | 2.94 |
2020 | 2.43 |
2019 | 2.36 |
2018 | 2.84 |
2017 | 3.27 |
2016 | 2.95 |
2015 | 3.00 |
2014 | 2.56 |
Pediatric Research h-index
The h-index of Pediatric Research is 165 . By definition of the h-index, this journal has at least 165 published articles with more than 165 citations.
What is h-index?
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
Pediatric Research ISSN
The International Standard Serial Number (ISSN) of Pediatric Research is/are as follows: 00313998, 15300447 .
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
Pediatric Research Ranking and SCImago Journal Rank (SJR)
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Pediatric Research Publisher
The publisher of Pediatric Research is Lippincott Williams and Wilkins Ltd. . The publishing house of this journal is located in the United States . Its coverage history is as follows: 1967-2022 .
Call For Papers (CFPs)
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
Abbreviation
The International Organization for Standardization 4 (ISO 4) abbreviation of Pediatric Research is Pediatr. Res. . ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Pediatr. Res.') can be used for citing, indexing, abstraction, and referencing purposes.
How to publish in Pediatric Research
If your area of research or discipline is related to Pediatrics, Perinatology and Child Health, etc. , please check the journal's official website to understand the complete publication process.
Acceptance Rate
- Interest/demand of researchers/scientists for publishing in a specific journal/conference.
- The complexity of the peer review process and timeline.
- Time taken from draft submission to final publication.
- Number of submissions received and acceptance slots
- And Many More.
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
Frequently Asked Questions (FAQ)
What is the impact score of pediatric research.
The latest impact score of Pediatric Research is 3.12. It is computed in the year 2023.
What is the h-index of Pediatric Research?
The latest h-index of Pediatric Research is 165. It is evaluated in the year 2023.
What is the SCImago Journal Rank (SJR) of Pediatric Research?
The latest SCImago Journal Rank (SJR) of Pediatric Research is 1.040. It is calculated in the year 2023.
What is the ranking of Pediatric Research?
The latest ranking of Pediatric Research is 3961. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Who is the publisher of Pediatric Research?
Pediatric Research is published by Lippincott Williams and Wilkins Ltd.. The publication country of this journal is United States.
What is the abbreviation of Pediatric Research?
This standard abbreviation of Pediatric Research is Pediatr. Res..
Is "Pediatric Research" a Journal, Conference or Book Series?
Pediatric Research is a journal published by Lippincott Williams and Wilkins Ltd..
What is the scope of Pediatric Research?
- Pediatrics, Perinatology and Child Health
For detailed scope of Pediatric Research, check the official website of this journal.
What is the ISSN of Pediatric Research?
The International Standard Serial Number (ISSN) of Pediatric Research is/are as follows: 00313998, 15300447.
What is the best quartile for Pediatric Research?
The best quartile for Pediatric Research is Q1.
What is the coverage history of Pediatric Research?
The coverage history of Pediatric Research is as follows 1967-2022.
Credits and Sources
- Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
- Journal Impact Factor, https://clarivate.com/
- Issn.org, https://www.issn.org/
- Scopus, https://www.scopus.com/
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series
Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
---|---|---|---|---|---|---|
Check complete list
Pediatric Research Impact Score (IS) Trend
Year | Impact Score (IS) |
---|---|
2023/2024 | Updated Soon |
2022 | 3.12 |
2021 | 2.94 |
2020 | 2.43 |
2019 | 2.36 |
2018 | 2.84 |
2017 | 3.27 |
2016 | 2.95 |
2015 | 3.00 |
2014 | 2.56 |
Top Journals/Conferences in Pediatrics, Perinatology and Child Health
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Publications
- Account settings
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .
- Advanced Search
- Journal List
- Springer Nature - PMC COVID-19 Collection
The state and future of pediatric research—an introductory overview
Esther m. speer.
1 Department of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY USA
Lois K. Lee
2 Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, MA USA
Florence T. Bourgeois
3 Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
Daniel Gitterman
4 Public Policy, University of North Caroline, Chapel Hill, NC USA
William W. Hay, Jr.
5 University of Colorado, Denver, CO USA
Jonathan M. Davis
6 Department of Pediatrics and the Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA USA
Joyce R. Javier
7 Department of Pediatrics, Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA USA
Associated Data
All data pertaining to this report are contained in this special article.
- This is an introduction to an article series devoted to the current state and future of pediatric research.
- The role of public–private partnerships, influencing factors, challenges, and recent trends in pediatric research are described, with emphasis on funding, drug and device development, physician-scientist training, and diversity.
- Potential solutions and advocacy opportunities are discussed.
Introduction
Children have unique and rapidly changing physical, psychosocial, and developmental needs. Addressing early-life diseases and adverse childhood experiences has lifelong benefits for individuals, families and communities. This may also limit or even prevent many chronic adult-onset diseases that originate in early life. However, most pediatric researchers face financial, regulatory, institutional, ethical, and career challenges (Table 1 ), placing pediatric research at a distinct disadvantage compared to adult investigations (Fig. 1 ).
Current challenges and potential solutions to promote pediatric research.
Stakeholders | Influencing factors and challenges | Potential solutions and opportunities |
---|---|---|
Pediatric patient , , | • Rapid growth and development • Unique and changing healthcare needs • Low disease frequency and burden • Emerging diseases (e.g., COVID-19) • • | • Lifelong benefit of prevention and therapy of early life diseases • ↓ Chronic adult disease burden • ↓ Healthcare costs and utilization • ↑ Workforce productivity • Advocacy initiatives |
Regulators and the public , , , | • Parental reluctance to enroll children in clinical trials • Recruitment • Ethical and safety concerns for clinical trials in children and pregnant women • Liability risk | • Community-based participatory research and parental engagement • Research network organizations • Centralized IRB approvals • Policies for inclusion of children in human subject research (e.g., NIH Inclusion Across the Lifespan Policy) • |
Academic institutions and pediatric departments , | • Pediatric payer mix (↑ Medicaid recipients) • Institutional funds flow disadvantageous to pediatrics • ↑ Provider costs • ↑ Regulatory requirements • ↓ Institutional funding • ↑ Consumer expectations • Competing institutional missions (teaching, research, and patient care) • Impact of COVID-19 | • Aligned strategic institutional funds flow • Institutional networks • Incorporation of pediatric research training and funding into departmental funding models • Adjusted compensation benchmarks and productivity models |
Extramural federal funding – , , | • Limited federal pediatric research funding • Unequal distribution of federal pediatric research expenditures • ↓ Pediatric research career awards • Limited industry and foundation funding • Increased costs of pediatric clinical trials • High inflation • Impact of COVID-19 | • Alignment of pediatric research funding with disease burden • NIH reporting requirements of pediatric research spending • Sustained growth of pediatric and perinatal federal research funding • Diversification of federal funding • Incentives and requirements for industry-sponsored pediatric trials • Advocacy for pediatric care and research funding |
Investigator – , | • Declining and aging pediatric scientist workforce • ↓ Physician-scientist training • ↑ Competing responsibilities (clinic, administration, education) • Individual career and lifestyle choices • ↑ Educational debt • Gender, equity and diversity challenges • Impact of COVID-19 on young and mid-level investigators | • Programs fostering inclusion of women and minorities in research • Integration of IMGs in the pediatric research workforce • Formal research training during residency and fellowship • Institutional and national research mentorship programs • Student debt forgiveness • NIH Loan Repayment Program • ↑ Early and mid-level federal pediatric research career awards • |
Experimental and trials design , , | • Limited pediatric disease models available • Variation in pediatric and neonatal clinical criteria and outcome measures • Prolonged observation • Impact on neurodevelopment • Increased costs of pediatric clinical trials | • Defining pediatric disease and outcome parameters internationally • Collaborative science • National and international research networks |
Pediatric drug and device developmental – | • Limited pediatric drugs and devices • Lack of FDA approval • Lack of safety and efficacy data for children | • Initiatives to improve pediatric clinical trial processes and device development ◦ SHIP-MD ◦ I-ACT for Children ◦ International Neonatal Consortium ◦ Best Pharmaceuticals for Children Act • Post-marketing surveillance and approvals |
Dissemination, data sharing and reuse , – | • Limited peer-reviewed publications of pediatric RCTs and systematic reviews • Lower quality of pediatric studies (small-scale, single-center) • Many uncompleted trials • Limited and delayed dissemination of results | • Reporting of clinical trial results in registries and data repositories • Data sharing and reuse • Enforcement of existing NIH and FDA policies ◦ NIH Policy on Data Sharing ◦ FDA Amendment Act ◦ |
The most important factors are highlighted as bold text.
I-ACT for Children Institute for Advanced Clinical Trials in Children, IMG international medical graduate, NIH National Institutes of Health, RCT randomized controlled trial, SHIP-MD System of Hospitals for Innovation in Pediatrics-Medical Devices.
Factors influencing pediatric research, pediatric health and disease, as well as adult health and disease are illustrated with arrows.
Federal research funding
Pediatric research funding from the National Institutes of Health (NIH), the largest public funding agency worldwide, has been historically low compared to funding for adult diseases. 1 , 2 Although pediatric NIH spending has increased over time, the purchasing power of their pediatric and perinatal research portfolio declined by 15.9% and 12.4%, respectively from 2004 to 2015. 2 Fortunately, pediatric funding has recently significantly increased due to fiscal and legislative responsiveness requiring NIH to report pediatric research spending annually. 3 Nonetheless, high inflation and the COVID-19 pandemic may place future pediatric research funding at risk. Furthermore, priorities for federal pediatric research support may need to be adjusted to account for rapidly changing healthcare needs 4 and pediatric disease burden. 5
Drug and device development
Pediatric drug and device development continues to lag behind programs addressing adult conditions. Industry-sponsored trials involving children remain limited due to expected lower profitability. Heightened regulatory, ethical, and safety standards for clinical trials involving pregnant women and children, and issues with obtaining parental informed consent and child assent highlight the considerable challenges. Most pediatric diseases are considered rare, which often results in trial prolongation and inadequate enrollment. 6 Pre-clinical models for many childhood diseases are lacking and designing pediatric studies requires multiple stakeholders; outcome measures are not uniformly standardized 7 and assessing the impact of interventions on neurodevelopmental outcomes can require years of follow-up. Many pediatric clinical research sites do not enroll a single patient, often due to limitations with a highly trained workforce. Consequently, most drugs and devices used in children are not approved by the US Food and Drug Administration (FDA) and approximately two-thirds of FDA-approved drugs and biologics with indications relevant to children are marketed for longer than 5 years without adequate pediatric safety and efficacy labeling. 8 Likewise, most FDA approvals of high-risk pediatric devices are based on adult trials, with few children exposed to these devices before market availability. 9
To address these shortcomings, several legislative and regulatory changes have been enacted. The Best Pharmaceuticals for Children Act (2002) incentivizes pharmaceutical companies to test drugs in children by giving them an additional 6 months of market exclusivity. The Pediatric Research Equity Act (2003) and the NIH Inclusion Across the Lifespan Policy (2017) mandate the inclusion of participants of all ages in human subject research. Several public–private partnerships and other national/international research collaborations have recently emerged, designed to streamline pediatric clinical trial processes and drug and device development. These include the International Neonatal Consortium (oversight by the Critical Path Institute), a global collaboration that focuses on novel regulatory pathways for evaluating the safety and effectiveness of neonatal therapies, 10 the FDA-sponsored System of Hospitals for Innovation in Pediatrics-Medical Devices initiative to accelerate pediatric device development, and the Institute for Advanced Clinical Trials for Children to facilitate multicenter studies for pediatric drug development.
Perspective of academic institutions
Academic medical institutions face increasing financial constraints due to: (1) external competition, (2) expanded regulatory requirements, (3) limited funding, (4) rising provider costs, (5) the need to educate junior physician-scientists, (6) increased costs of conducting high-quality research, and (7) providing medical care to a diverse population with limited reimbursement. 11 , 12 Pediatric departments are especially impacted by financial burdens due to increasing proportions of Medicaid recipients, heightened consumer expectations and regulatory requirements, limited NIH and industry funding, and escalating medical costs. 11 These limitations can reduce support for pediatric research infrastructure and training. New organizational and aligned strategic funding models incorporating departmental research support may help to overcome these challenges. 11 Improved federal funding is also essential to train the pediatric physician workforce, as requested by the American Hospital Association and 25 other healthcare organizations. 13
Physician-scientist training
Pediatric NIH funding is increasingly concentrated in relatively few research-intensive institutions, challenging diversity in research and further impacting the physician-scientist pipeline. Over a 5-year period, 15 institutions received 63% of all pediatric R01-equivalent NIH awards. 14 The majority of R01-funded pediatric physician-scientists were male (63.6%), full professors (58%), and held senior leadership positions (24%). Only 15% of pediatric R01-awards were granted to non-professor physician-scientists. 14 Furthermore, the success rate for NICHD career development awards has declined since 2010. 14 The limited support for junior pediatric physician-scientists, compounded by individual career choices and competing clinical responsibilities, has created a declining and aging pediatric research workforce. This may limit future discoveries and innovative therapies for children. 15 Several recent initiatives are now addressing this gap. One example is the National Pediatric Physician-Scientist Collaborative Workgroup, a collaborative of physician-scientists, graduate medical education leaders, department chairs, and trainees from 19 pediatric programs across the US which aims to strengthen the pediatric physician-scientist pipeline. 16 Mentorship at the institutional, regional and national level fosters networking opportunities and support for aspiring pediatric researchers. Another important program includes the NIH Loan Repayment Program to recruit and retain highly qualified health professionals into research careers. Offering early-career formal research education during medical school and physician training can lead to greater future academic productivity and funding success, thus strengthening the physician-scientist workforce. 17
Gender and racial/ethnic diversity
Despite comparable enrollment in medical schools, women account for only 18% of hospital chief executive officers and 16% of all deans and department chairs in the US. 18 Women remain in the minority as senior authors (10%) and editors-in-chief (7%) at high-ranking medical journals. 18 They also comprise less than one-third of NIH-awardees, even though they are as successful as men in obtaining first-time grants. 19 Factors contributing to these disparities include implicit gender bias and institutional policies disadvantaging women. Early-stage investigator or career development grants sponsored by NIH or other funders are limited to scientists who finished their training within 10 years, which disproportionately disadvantages women. 20 Race and ethnicity also impact career trajectories of physician researchers. 21 The Coalition for Pediatric Medical Research is now addressing the need to train the next generation of diverse pediatric researchers. Furthermore, innovative solutions to integrate international medical graduates into the research workforce in addition to increased funding for US-trained physicians represent one strategy to address the current physician-scientist shortage. 22 Finally, clinical studies must be designed to improve the participation of underrepresented populations, 23 to ensure that drugs and devices are studied in target populations who will benefit most from such interventions. This can be accomplished through community-based participatory research including parental engagement for pediatric trials. 24
Dissemination, data sharing and reuse
Timely dissemination of trial results through peer-reviewed publications, registries, and data depositories are imperative to facilitate evidence-based care and decision-making. The FDA Amendments Act (2007) and the NIH require that trials are prospectively registered in CinicalTrials.gov and that summary results of FDA-regulated or NIH-funded interventional trials are made available within 12 months of primary study completion. However, only 39% of registered pediatric trials reported results in peer-reviewed publications and 23.5% in the ClinicalTrials.gov registry by 3 years. 25 Notably, 11% of trials were discontinued early, with recruitment failure as the most common cause. 25 The NIH Policy on Data Sharing (2003) requires a data-sharing plan in all grant applications and the International Committee of Medical Journal Editors (LCMJE) requires a data-sharing statement. However, less than a third of LCMJE-affiliated journals have implemented a data-sharing policy and only a few published trials provided individual patient data in repositories. 26 , 27 Improved monitoring and incentives for data sharing and timely dissemination of trial results may overcome these problems.
Implications for patient outcomes
High-level evidence from clinical studies remains limited for many pediatric diseases and interventions. Most pediatric studies registered in ClinicalTrials.gov are small-scale, single-center, and not funded by industry or the federal government, which translates into fewer drugs being studied over time. 28 Published pediatric studies involve significantly fewer randomized controlled trials (RCTs), systematic reviews, and therapeutic trials compared to adults. 29 This has significant implications for child health with preterm birth and neonatal infections remaining the leading causes of mortality during the first month of life, accounting for approximately half of the 2.4 million neonatal deaths annually worldwide; there has been limited progress over the past 2 decades due in part to a lack of quality RCTs in this area. 30 – 32
There remains an urgent need to communicate 33 and advocate healthcare institutions, elected officials, funders, and the public that promoting research focused on fetal and early life has lifelong benefits for children, adults, and society. 34 The COVID-19 pandemic has proven that advances in pediatric and adult research can be achieved expediently, especially when governments promote the development of public–private partnerships and global collaboration. Broad support for NIH-sponsored pediatric and perinatal research, enforcement of existing NIH and FDA mandates related to clinical trial reporting, data sharing and reuse, inclusion of children in clinical research, collaborative science, and advocacy hold great promise to advance research and benefit children and future adults.
Author contributions
E.M.S. wrote the initial draft of the manuscript. All authors substantially contributed to the conception and content of the article, critically revised the manuscript for important intellectual content, and approved the final version for publication.
Data availability
Competing interests.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Editage One platform for all researcher needs
- Paperpal AI-powered academic writing assistant
- R Discovery Your #1 AI companion for literature search
- Mind the Graph AI tool for graphics, illustrations, and artwork
- [email protected]
- Request a callback
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Pediatric Research : Impact Factor & More
Check your submission readiness.
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Pediatric Research is a monthly peer-reviewed medical journal in the field of pediatrics and the official publication of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research. It is published for the International Pediatric Research Foundation by Springer Nature. The editor-in-chief is Cynthia F. Bearer. The journal had a 2020 impact factor of 3.75. Less
Pediatric Research Key Metrics
Topics covered on pediatric research, pediatric research journal specifications.
IMAGES
VIDEO
COMMENTS
Pediatric Research 's mission statement Optimize children's health by publishing and communicating peer reviewed science and to foster the development of future pediatric researchers.
Pediatric Research publishes original translational research papers, invited reviews, and commentaries on the etiologies and treatment of diseases of children ...
A list of journals in the category of pediatrics, perinatology and child health, ranked by SJR (SCImago Journal Rank) and other metrics. See the impact factor, citation rate, document count and other data for each journal.
Pediatric Research is a high-impact journal that publishes original translational research papers on pediatric diseases and disorders. It has a SJR of 1.184 in 2023, an H-Index of 171, and ranks first in the category of Pediatrics, Perinatology and Child Health.
Resurchify provides information on Pediatric Research, a journal covering pediatrics, perinatology and child health. See its impact factor, h-index, SJR, ranking, publisher, ISSN and more.
2023 Jul - Dec 2023 Volume 94 Jan - Jun 2023 Volume 93 Browse all the volumes of Pediatric Research
Pediatric Research is a monthly peer-reviewed medical journal in the field of pediatrics and the official publication of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research. It is published for the International Pediatric Research Foundation by Springer Nature.
PEDIATRIC RESEARCH is a pediatrics journal with an impact factor of 3.1 and a 5-year impact factor of 3.5. It is ranked in the top quartile (Q1) of pediatrics journals and supports hybrid and open access publication.
About Pediatric Research Pediatric Research is a journal published by Lippincott Williams and Wilkins Ltd.. This journal covers the area [s] related to Pediatrics, Perinatology and Child Health, etc. The coverage history of this journal is as follows: 1967-2022. The rank of this journal is 3961. This journal's impact score, h-index, and SJR are 3.12, 165, and 1.040, respectively. The ISSN of ...
The Journal of Pediatrics is an international peer-reviewed journal that advances pediatric research and serves as a practical guide for pediatricians who manage health and diagnose and treat disorders in infants, children, and adolescents. The Journal publishes original work based on standards of ….
Pediatrics is an official peer-reviewed journal of the American Academy of Pediatrics (AAP). It has been continuously published by the AAP since January 1948. Pediatrics publishes original research, clinical observations, and special feature articles in the field of pediatrics, as broadly defined. Contributions pertinent to pediatrics are also ...
The Lancet Child & Adolescent Health is an internationally trusted source of clinical, public health, and global health knowledge. With an Impact Factor of 19·9, ranking second out of 186 paediatrics journals (2023 Journal Citation Reports ®, Clarivate 2024), and a CiteScore of 40·9, ranking first out of 330 paediatrics, perinatology, and ...
Impact. This is an introduction to an article series devoted to the current state and future of pediatric research. The role of public-private partnerships, influencing factors, challenges, and recent trends in pediatric research are described, with emphasis on funding, drug and device development, physician-scientist training, and diversity.
Know all about Pediatric Research - Impact factor, Acceptance rate, Scite Analysis, H-index, SNIP Score, ISSN, Citescore, SCImago Journal Ranking (SJR), Aims & Scope, Publisher, and Other Important Metrics. Click to know more about Pediatric Research Review Speed, Scope, Publication Fees, Submission Guidelines.
Impact. This is an introduction to an article series devoted to the current state and future of pediatric research. The role of public-private partnerships, influencing factors, challenges, and ...
Get access to Pediatric Research details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). Check top authors, submission guidelines, Acceptance Rate, Review Speed, Scope, Publication Fees, Submission Guidelines at one place. Improve your chances of getting published in Pediatric Research with Researcher.Life.
The quality and the quantity of research we receive has enabled JAMA Pediatrics to continue to be one of the preeminent pediatric journals in the world as evinced by the Journal Impact Factor, which is now 26.1.
Explore the Pediatrics journal by the American Academy of Pediatrics, featuring peer-reviewed research and insights in child health.
Journal Impact Factor of 26.1, one of the highest ranking among pediatrics journals. Broad reach through author audio interviews, editor podcasts, email alerts, social media, and multimedia.
The Journal of Pediatric Research is an open access, scientific, double-blind peer-reviewed journal in the field of general pediatrics and pediatric subspecialties.
IMPACT: This is an introduction to an article series devoted to the current state and future of pediatric research. The role of public private partnerships, influencing factors, challenges, and ...
Pediatric Research is a monthly peer-reviewed medical journal in the field of pediatrics and the official publication of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research.
Explore the latest in child health including food and nutrition, Kawasaki disease and C difficile, effects of media, and more. Formerly Archives of Pediatrics.
Enter your email to receive alerts when new articles and issues are published.